OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Nasopharyngeal carcinoma is the most common malignant tumor of the nasopharynx, the upper part of the throat behind the nose and near the base of skull. A carcinoma is a cancer that starts in epithelial cells ? the cells lining the internal and external surfaces of the body. The standardized incidence ratio (SIR) of nasopharyngeal carcinoma is 0.69 out of 2597587 males and 0.96 out of 3655773 females. As compared to the native Finland population, the risk of nasopharyngeal carcinoma was significantly higher in male (SIR=35.6) and female (24.6) Southeast Asians.
Treatment for nasopharyngeal carcinoma usually involves radiation therapy, chemotherapy or a combination of the two. In certain cases, surgery may be used to remove a tumor from the nasopharynx. This usually requires surgeons to make an incision in the roof of your mouth to access the area to remove the cancerous tissue. There is a need to conduct secondary prevention, such as improving rates of early detection, early diagnosis, and early treatment in NPC patients. Achievements in these areas might bring hope of providing a successful screening model in cancer
